Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 2 de 2
1.
Hellenic J Cardiol ; 58(5): 369-371, 2017.
Article En | MEDLINE | ID: mdl-27986618

Calcium channel blockers (CCBs) have a narrow therapeutic index, and their intake in excess is associated with a critical clinical presentation of sustained hypotension and non-cardiogenic pulmonary edema, which are difficult to treat. Unfortunately, the available treatments fail to resuscitate a significant number of patients poisoned by CCBs, rendering them the main cardiovascular drugs involved in death due to overdose. Importantly, in all cases reported until now in the literature, CCB intoxication was known at the time of patients' presentation and the medical challenge solely consisted of the therapeutic approach. In this case report, we describe our experience in treating a 72-year-old patient with recurrent episodes of sustained hypotension refractory to crystalloid and vasoconstrictor infusions. Prolonged pharmacologic support and intermittent sessions of hemofiltration induced stabilization and recovery. The results of an extensive diagnostic workup to elucidate the cause were unfruitful. The recurrent and paroxysmal nature of the clinical presentation along with its incidence after the patient left the protected setting of the hospital led the diagnostic approach to search for a possible external factor, which was shown to be, after toxicological investigation, unintentional amlodipine intoxication.


Amlodipine/poisoning , Blood Pressure/drug effects , Hypotension/etiology , Shock/chemically induced , Vasodilation/drug effects , Aged , Amlodipine/therapeutic use , Calcium Channel Blockers/poisoning , Calcium Channel Blockers/therapeutic use , Drug Overdose , Humans , Hypertension/drug therapy , Hypertension/physiopathology , Hypotension/physiopathology , Male , Recurrence , Shock/physiopathology
2.
Angiology ; 62(8): 636-40, 2011 Nov.
Article En | MEDLINE | ID: mdl-21511678

This study investigated whether switching from a diet rich in saturated fatty acids (SAFAs) to a diet rich in monounsaturated fatty acids (MUFAs) or to one with equal amounts of MUFAs-SAFAs favorably affects the lipid profile of hypercholesterolemic mice. C57BL/6 mice (n = 82) were allocated into 4 groups. The first group (control, n = 10) was fed standard chow. The 3 remaining groups (n = 24 mice/group) were fed a SAFA-rich diet for 8 weeks and were then allocated for 16 weeks to either a MUFA-rich diet, an equal in MUFAs-SAFAs-rich diet, or continued the previous SAFA-rich diet. After 8 weeks, mice consuming SAFA-rich diet had increased weight, total cholesterol (TC), and high-density lipoprotein cholesterol (HDL-C) levels (P < .05 vs baseline). At week 24, MUFA-rich and MUFA-SAFA rich diets decreased TC and low-density lipoprotein cholesterol (LDL-C) levels (P < .05) compared with week 8. In conclusion, switching to MUFA-rich diets or substituting half of the SAFAs with MUFAs can reverse diet-induced-hypercholesterolemia.


Fatty Acids, Monounsaturated/therapeutic use , Fatty Acids/pharmacology , Hypercholesterolemia/diet therapy , Lipids/blood , Animals , Dietary Fats/pharmacology , Disease Models, Animal , Hypercholesterolemia/blood , Male , Mice , Mice, Inbred C57BL , Treatment Outcome
...